Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ColgatePalmolive

3 Rock-Solid Dividend Stocks to Invest in Now

Morgan Stanley recommends Coca-Cola, Colgate-Palmolive, and Verizon as top dividend stocks for the current economic climate, highlighting their consistent dividend payments, strong market positions, and financial stability.

Barchart

Only 49 companies have been on the Fortune 500 for all 70 years. Here are their secrets to staying in power

Prolonged success boils down to a few subtle factors—but surprisingly, they don't include strategy, structure, technology, or even culture.

Fortune

Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock?

Colgate-Palmolive has outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Stock Index Futures Climb on Upbeat Big Tech Earnings, U.S. Inflation Data Looms

June S&P 500 E-Mini futures (ESM24) are up +0.63%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.86% this morning as upbeat quarterly results from tech titans Alphabet and Microsoft boosted sentiment, while investors geared up for the release of the Fed’s preferred inflation gauge.

Barchart

3 Safe Stocks to Buy After Goldman Sachs CEO's Cautious Economic Comments

Here's why blue-chip dividend stocks, such as Coca-Cola, deserve a place in investors' portfolios in 2024.

Barchart

3 Stocks to Buy if You Believe Jeffrey Gundlach's Prediction of an Impending Recession

Consumer staples stocks, such as Kroger and Sysco, can help you create a defensive moat for your portfolio if the U.S. economy enters a recession next year.

Barchart

Colgate-Palmolive (CL): When Good News Might Be Bad News for the Economy

Institutional love for CL stock suggests potential economic caution as bullish sentiment on essential goods like Colgate-Palmolive might hint at broader market vulnerabilities.

Barchart

Read news from The Economist, FT, and more,
with one subscription

S&P Futures Tick Lower Ahead of Key U.S. Inflation Data

June S&P 500 futures (ESM23) are trending down -0.33% this morning after three major U.S. benchmark indices rallied on Thursday as technology stocks continued to shine, while investors braced for a reading on the Federal Reserve’s preferred inflation gauge.

Barchart

Fabuloso recall 2023: Full list of products that have been recalled

Everything you need to know about the Fabuloso recall, from which products have been removed from shelves to why the recall has been announced.

GoodToKnow

McDonald’s Executive Slam Elon Musk In Eye-Opening Email, Say Tweets Are ‘Perpetuating Racism’

A top executive at McDonald'sVreportedly asserted that Twitter CEO Elon Musk's "free speech" agenda at Twitter

Zenger

Elon Musk is accused by advertisers of 'perpetuating racism' on Twitter

Elon Musk's behavior as Twitter CEO and changes at the company are still off-putting to potential advertisers.

Fortune

4.9 million Fabuloso bottles are recalled over the risk of bacteria contamination

The products were sold online and at major retailers. As of the recall, no incidents or injuries had been reported.

WEKU

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Upgrades

Benzinga

Shrinkflation bites as popular Snickers bar gets downsized

The New Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022

Upgrades

Benzinga

Looking Into Colgate-Palmolive's Recent Short Interest

Colgate-Palmolive's (NYSE:CL) short percent of float has fallen 5.03% since its last report. The company recently reported that it has 14.22 million shares sold short, which is 1.7% of all regular shares that are available for trading.

Benzinga

Golden Cross Appears Before Colgate-Palmolive Investors

If history is any guide, there may be good fortune ahead for shares of Colgate-Palmolive (NYSE:CL). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Looking Into Colgate-Palmolive's Recent Short Interest

Colgate-Palmolive's (NYSE:CL) short percent of float has risen 26.96% since its last report. The company recently reported that it has 12.25 million shares sold short, which is 1.46% of all regular shares that are available for trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Colgate-Palmolive's Return On Invested Capital Insights

Pulled from Benzinga Pro data, Colgate-Palmolive (NYSE:CL) posted Q1 earnings of $603.00 million, an increase from Q4 of 220.74%. Sales dropped to $4.40 billion, a 0.09% decrease between quarters.

Benzinga

Barclays Maintains Equal-Weight Rating for Colgate-Palmolive: Here's What You Need To Know

Barclays has decided to maintain its Equal-Weight rating of Colgate-Palmolive (NYSE:CL) and lower its price target from $81.00 to $77.00. Shares of Colgate-Palmolive are trading down 0.3% over the last 24 hours, at $74.95 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

What 7 Analyst Ratings Have To Say About Colgate-Palmolive

Colgate-Palmolive (NYSE:CL) has observed the following analyst ratings within the last quarter:

Benzinga

Recap: Colgate-Palmolive Q1 Earnings

Colgate-Palmolive (NYSE:CL) reported its Q1 earnings results on Friday, April 29, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Colgate-Palmolive's Earnings Outlook

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Colgate-Palmolive will report an earnings per share (EPS) of $0.75.

Benzinga

Expert Ratings For Colgate-Palmolive

Analysts have provided the following ratings for Colgate-Palmolive (NYSE:CL) within the last quarter:

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.